In2cure AB
Investor
In2cure AB
Description
development of proprietary peptide-based drugs for prevention and treatment of inflammatory diseases and infections
In2cure AB
Address
Scheelevägen 2, Medicon Village, 22361 Lund
Lund
Lund
Contact
helene.hartman@in2cure.com
Description
development of proprietary peptide-based drugs for prevention and treatment of inflammatory diseases and infections
Matchmaking
Connect with In2cure AB
This entity is yours?
Update informationPosition on the value chain
With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.
Bio-resources and biobanking
- Cells, tissues and humanized xeno-organs
- Biosamples
- Viral, phage or bacterial specimen
Identification of biotherapies
- Target identification
- Target validation
- Screening
Drug design
- Drug assessment
- Drug engineering
- In vitro preclinical studies
Clinical validation
- Clinical trials
- In vivo preclinical validation
- Pre-industrial scale production
Production
- Upstream processes
- Downstream processes
- Quality control
Market access
- CE mark / market authorisation
- Payment / Reimbursement
- Care pathways